Morgan Stanley

The World Bank is keen to bring a euro benchmark this year, having been absent from that segment for nearly two years. The supranational this week made a triumphant return to dollars, setting a 2018 record for the tightest swap spread on a three year dollar benchmark so far.

Shanghai Fosun Pharmaceutical Group bagged HK$2.6bn ($331m) from an H-share placement on Wednesday, its first capital raise in more than a year.

Bankers marketing the latest crop of IPOs from China’s technology sector got their game face on this week amid escalating fears of a trade war with the US.

Ascletis Pharma is in the market with the first biotechnology IPO in Hong Kong following the bourse’s historic change in listing rules.

Goldman’s new CEO David Solomon has a lot in his in-tray, not least a resurgent Morgan Stanley that has firmly hit its stride, writes David Rothnie.

World Bank on Wednesday returned following an eight month absence in dollar benchmark funding to print the tightest spread on a three year dollar deal from an SSA this year.

The San Francisco Public Utilities Commission (SFPUC) is looking for international buyers of its green bonds for the first time as it prepares a roughly $402m new issue.

HDFC Asset Management is gunning for up to Rp28bn ($408m) from its IPO in India after setting the final price guidance for the offering.

Chinese firm Ascletis Pharma has launched bookbuilding for a HK$3.58bn ($456.9m) IPO, the first company to take advantage of the Hong Kong Stock Exchange’s new biotechnology-friendly listing regime.

CanSino Biologics, founded by a group of Chinese vaccination industry experts from Canada, has filed for a listing in Hong Kong.

World Bank could set a new spread tight for the calendar year in the short end of the dollar market, after sending out initial price thoughts for a three year global benchmark on Tuesday.

Lodha Developers may hit screens with its Rp50bn ($732m) IPO in India next month as the lead banks wait for markets to calm down.